
CagriSema: Novo Nordisk’s New Weight Loss Drug Hit 22.7% — Here’s What That Means for Colorado Patients
CagriSema: Novo Nordisk’s New Weight Loss Drug Hit 22.7% — Here’s What That Means for Colorado Patients Novo Nordisk’s stock dropped 9%…

CagriSema: Novo Nordisk’s New Weight Loss Drug Hit 22.7% — Here’s What That Means for Colorado Patients Novo Nordisk’s stock dropped 9%…

A patient came in last month with a fatty liver diagnosis and an A1C of 6.2%. She was not surprised. Her father…

Sleep deprivation adds 385 calories a day to your intake — not because you lack willpower, but because your hormones are working against you. Here's what the science says.

Teenagers With Obesity Aren’t Waiting for the Operating Room Anymore A study published in JAMA Pediatrics on July 20, 2026, by Messiah…

For years, patients asked about a pill version of GLP-1 medication. “Anything I can swallow instead of inject?” The answer used to…

Good news for Colorado state employees: GLP-1 medications for weight loss are a covered benefit again. Effective May 1, 2026, the State…

Stopping vs. Switching — They’re Not the Same Thing Before anything else: there’s an important distinction between stopping a GLP-1 and switching…

Patients on GLP-1 medications are eating far less than they used to — sometimes dramatically so. And still, many of them are…

Let me start with a number that should get your attention: 28.7%. That’s how much body weight participants lost in the latest…